Floto Group (@flotocambridge) 's Twitter Profile
Floto Group

@flotocambridge

The Floto lab, within the VPD Heart Lung Research Institute, studies how bacteria interact with humans and how to create antibiotics using ML

ID: 2804448251

linkhttp://www.flotolab.com calendar_today04-10-2014 09:48:48

89 Tweet

390 Followers

281 Following

Aaron Weimann 🇺🇦 (@aaron_weimann) 's Twitter Profile Photo

Pre-print alert: A novel DNA sequence-to-MIC prediction model with applications to Mycobacterium tuberculosis and Pseudomonas aeruginosa. Transfer learning with gene expression data improves accuracy! Great team effort led by Maciej Wiatrak . Thread ⬇️

Enterprise Therapeutics (@enterprisethera) 's Twitter Profile Photo

We have closed our £26m Series B follow-on #investment — an achievement that will fund our Phase 2a #clinical #proofofconcept trial in #cysticfibrosis for ETD001, as well as our other #preclinical programmes targeting mucus congestion. Read here: rb.gy/kr6wf5

We have closed our £26m Series B follow-on #investment — an achievement that will fund our Phase 2a #clinical #proofofconcept trial in #cysticfibrosis for ETD001, as well as our other #preclinical programmes targeting mucus congestion.

Read here: rb.gy/kr6wf5
Aaron Weimann 🇺🇦 (@aaron_weimann) 's Twitter Profile Photo

Great to hear I've received an Outstanding Reviewer Award for reviewing for Microbiology Society Microbial Genomics last year for the second time (after 2021). Proud to support a society journal. Thanks to EIC Sheppard Lab.

Great to hear I've received an Outstanding Reviewer Award for reviewing for <a href="/MicrobioSoc/">Microbiology Society</a> Microbial Genomics last year for the second time (after 2021).  Proud to support a society journal. Thanks to EIC <a href="/sheppard_lab/">Sheppard Lab</a>.
Kate Baker (@ksbakes) 's Twitter Profile Photo

Was such a nice day getting to hear about all the amazing infection research yesterday. Thanks for organizing Cambridge Infectious Diseases IRC - already looking forward to next year!

Aaron Weimann 🇺🇦 (@aaron_weimann) 's Twitter Profile Photo

Much needed publicity for the pressing problem of antimicrobial resistance in a major news outlet featuring the Prof. Dame Sally Davies Prof Dame Sally Davies theguardian.com/global-develop…

Cambridge Centre for AI in Medicine (@cc4aim) 's Twitter Profile Photo

Our timetable for our AI and machine learning in healthcare #SummerSchool is taking shape! Have a peek at our preliminary schedule and secure your spot to dive into all those exciting topics! Find all the information here: vanderschaar-lab.com/ccaim-ai-and-m…

Our timetable for our AI and machine learning in healthcare #SummerSchool is taking shape! Have a peek at our preliminary schedule and secure your spot to dive into all those exciting topics! Find all the information here: vanderschaar-lab.com/ccaim-ai-and-m…
Wellcome Sanger Institute (@sangerinstitute) 's Twitter Profile Photo

How does the lung microbiome affect human health? 🫁 Group leader Josie Bryant shares with us her career journey & research aims to improve treatment for patients with chronic lung conditions, including cystic fibrosis. sangerinstitute.blog/2022/06/30/bre… #CFWeek #cysticfibrosis

Cystic Fibrosis Trust (@cftrust) 's Twitter Profile Photo

On #ResearchAppreciationDay, we're celebrating the advances in CF care and treatment thanks to research. 🫁 Today, Trust-funded researchers published important findings on CF lung infections in the journal Science. Dr. Aaron Weimann explains more. ➡️ ow.ly/lXXg50SvQzJ

Aaron Weimann 🇺🇦 (@aaron_weimann) 's Twitter Profile Photo

It was great to discuss our paper with the amazing Zakiya Whatley for the Science Magazine podcast. Tune in from 17:50 science.org/content/podcas… to hear about how LinkedIn Premium played a role in our discovery.

Mihaela van der Schaar (@mihaelavds) 's Twitter Profile Photo

I'm deeply honoured to be this year's recipient of the Johann Anton Merck Award! I am grateful for this recognition and eager to continue developing cutting-edge AI that can transform healthcare, empowering clinicians and patients! Merck Cambridge University Cambridge Centre for AI in Medicine

I'm deeply honoured to be this year's recipient of the Johann Anton Merck Award! I am grateful for this recognition and eager to continue developing cutting-edge AI that can transform healthcare, empowering clinicians and patients! <a href="/merckgroup/">Merck</a> <a href="/Cambridge_Uni/">Cambridge University</a> <a href="/CC4AIM/">Cambridge Centre for AI in Medicine</a>
Science Magazine (@sciencemagazine) 's Twitter Profile Photo

A new Science study describes the key sequential steps involved in the evolution of Pseudomonas aeruginosa from an environmental organism to a major human pathogen. 📄: scim.ag/7K4

A new Science study describes the key sequential steps involved in the evolution of Pseudomonas aeruginosa from an environmental organism to a major human pathogen.

📄: scim.ag/7K4
Cambridge Centre for AI in Medicine (@cc4aim) 's Twitter Profile Photo

The Cambridge Centre for AI in Medicine is pleased to announce a strategic collaboration with AstraZeneca, Boehringer Ingelheim, and GSK, to leverage AI and machine learning to innovate medical research with the potential to enhance patient outcomes globally: damtp.cam.ac.uk/ccaim-announce…

Josie Bryant (@josie_m_b) 's Twitter Profile Photo

Metagenomics postdoc fellowship available. We are looking for a talented individual who is willing to take on challenging datasets and develop new analytical approaches

Aaron Weimann 🇺🇦 (@aaron_weimann) 's Twitter Profile Photo

Tune into a Pseudomonas genomics webinar tomorrow at 11 UTC organised by ESGEM.SG to hear me present our paper on the evolution of Pseudomonas aeruginosa science.org/doi/10.1126/sc… and talks from Adesola Olalekan and Sara Cortes Lara. Register here: us06web.zoom.us/webinar/regist…

Aaron Weimann 🇺🇦 (@aaron_weimann) 's Twitter Profile Photo

Exciting PhD studentship opportunity on understanding chemical permeability to advance antibiotic drug discovery Floto Group jobs.cam.ac.uk/job/50800/. Combines experimental approaches with in silico screening and generative AI.